Skip to main content

Table 1 Demographic data

From: Extracellular volume fraction measurement correlates with lymphocyte abundance in thymic epithelial tumors

Variables

Number (n = 31)

Gender, male (%)

14 (45.2%)

Agea

56.00 (52.00, 64.00)

MG

4 (12.9%)

Tumor size (cm)a

5.75 (4.50, 8.88)

First-line treatment

 VATS

17 (54.8%)

 Sternotomy

8 (25.8%)

 Chemotherapy

6 (19.4%)

Mosaoka-Koga stage

 I

11 (35.5%)

 II

7 (22.6%)

 III

5 (16.1%)

 IV

8 (25.8%)

WHO classification

 A

4 (12.9%)

 AB

7 (22.6%)

 B1

2 (6.5%)

 B2

9 (29.0%)

 B3

1 (3.2%)

 Carcinoma

8 (25.8%)

  1. Note.—Unless otherwise indicated, data are the number of patients, with the percentage in parentheses. VATS = video-assisted thoracic surgery
  2. a Data are the median, with the first and third quartile in parentheses